Literature DB >> 7000306

Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs.

D I Edwards.   

Abstract

The selectively toxic effect of nitroimidazole drugs towards anaerobic bacteria and protozoa depends on a number of factors. The killing action of such drugs as metronidazole requires the reduction of the nitro group, a process which influences the rate of entry of the drug into the susceptible cell and which is determined by mechanisms involving ferredoxin-linked (or the equivalent) reactions in the cell. The reduced agent subsequently causes strand breakage of DNA, the extent of which depends on the A + T content of the DNA. Other effects of such drugs may include the possible inhibition of DNA repair mechanisms which exacerbate DNA damage, Inhibition of activity of nitroimidazoles may be caused by aminothiol radical scavengers and radioprotectors normally present in the cell or by the presence of other organisms in the environment (that is, the vagina) capable of inactivating the drugs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000306      PMCID: PMC1045807          DOI: 10.1136/sti.56.5.285

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  35 in total

1.  Inactivation of metronidazole by aerobic organisms.

Authors:  D I Edwards; E J Thompson; J Tomusange; D Shanson
Journal:  J Antimicrob Chemother       Date:  1979-05       Impact factor: 5.790

2.  TREATMENT OF VINCENT'S STOMATITIS WITH METRONIDAZOLE.

Authors:  A H DAVIES; J A MCFADZEAN; S SQUIRES
Journal:  Br Med J       Date:  1964-05-02

3.  Effect of tinidazole, metronidazole and nitrofurazone on nucleic acid synthesis in Clostridium bifermentans.

Authors:  C W Plant; D I Edwards
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

4.  The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms.

Authors:  R M Ings; J A McFadzean; W E Ormerod
Journal:  Biochem Pharmacol       Date:  1974-05-01       Impact factor: 5.858

5.  Metronidazole in amoebic dysentery and amoebic liver abscess.

Authors:  S J Powell; I MacLeod; A J Wilmot; R Elsdon-Dew
Journal:  Lancet       Date:  1966-12-17       Impact factor: 79.321

6.  The effect of nitroheterocyclic drugs on DNA: an in vitro model of cytotoxicity.

Authors:  D A Rowley; R C Knight; I M Skolimowski; D I Edwards
Journal:  Biochem Pharmacol       Date:  1979-10-01       Impact factor: 5.858

7.  Assay conditions and the demonstration of nitroimidazole resistance in Tritrichomonas foetus.

Authors:  J G Meingassner; H Mieth; R Czok; D G Lindmark; M Müller
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

8.  Bacteroides fragilis resistant to metronidazole after long-term therapy.

Authors:  H R Ingham; S Eaton; C W Venables; P C Adams
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

9.  Clinical trials with metronidazole in human balantidiasis.

Authors:  A Garcia-Laverde; L de Bonilla
Journal:  Am J Trop Med Hyg       Date:  1975-09       Impact factor: 2.345

10.  In vivo evaluation of the radiosensitizing and cytotoxic properties of newly synthesized electron-affinic drugs.

Authors:  J M Brown; N Y Yu; M J Cory; R B Bicknell; D L Taylor
Journal:  Br J Cancer Suppl       Date:  1978-06
View more
  19 in total

1.  The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst.

Authors:  Robin E Pearce; Michael Cohen-Wolkowiez; Mario R Sampson; Gregory L Kearns
Journal:  Drug Metab Dispos       Date:  2013-06-27       Impact factor: 3.922

Review 2.  Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions.

Authors:  Kari A Mergenhagen; Bethany A Wattengel; Megan K Skelly; Collin M Clark; Thomas A Russo
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

3.  MEchanisms of selective toxicity of metronidazole and other nitroimidazole drugs.

Authors:  J G Meingassner
Journal:  Br J Vener Dis       Date:  1981-08

Review 4.  Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.

Authors:  Sarah L Cudmore; Kiera L Delgaty; Shannon F Hayward-McClelland; Dino P Petrin; Gary E Garber
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis--A case report.

Authors:  J Kulda; M Vojtĕchovská; J Tachezy; P Demes; E Kunzová
Journal:  Br J Vener Dis       Date:  1982-12

6.  Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms.

Authors:  Dorothy F Newton; Sandra Macfarlane; George T Macfarlane
Journal:  Antimicrob Agents Chemother       Date:  2013-02-12       Impact factor: 5.191

7.  Ferredoxin-linked reduction of metronidazole in Clostridium pasteurianum.

Authors:  D L Lockerby; H R Rabin; L E Bryan; E J Laishley
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

8.  Fidaxomicin inhibits spore production in Clostridium difficile.

Authors:  Farah Babakhani; Laurent Bouillaut; Abraham Gomez; Pamela Sears; Ly Nguyen; Abraham L Sonenshein
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

Review 9.  Metronidazole vaginal gel 0.75% (MetroGel-Vaginal): a brief review.

Authors:  A M Wain
Journal:  Infect Dis Obstet Gynecol       Date:  1998

10.  Insights into the Mechanism of Action of Bactericidal Lipophosphonoxins.

Authors:  Natalya Panova; Eva Zborníková; Ondřej Šimák; Radek Pohl; Milan Kolář; Kateřina Bogdanová; Renata Večeřová; Gabriela Seydlová; Radovan Fišer; Romana Hadravová; Hana Šanderová; Dragana Vítovská; Michaela Šiková; Tomáš Látal; Petra Lovecká; Ivan Barvík; Libor Krásný; Dominik Rejman
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.